Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder

Archives of General Psychiatry

Volumn 62, Issue 9, 2005, Pages 996-1004

  Frank, Ellen ^a   Kupfer, David J ^a   Thase, Michael E ^a   Mallinger, Alan G ^a   Swartz, Holly A ^a   Fagiolini, Andrea M ^a   Grochocinski, Victoria ^a   Houck, Patricia ^a   Scott, John ^a   Thompson, Wesley ^a   Monk, Timothy ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PATIENT REFERRAL; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY; SURVIVAL; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTERPERSONAL RELATIONS; LITHIUM; MALE; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 24344489477     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.62.9.996     Document Type: Article

References (66)

1. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med. 1989;321:1489-1493.
2. Harrow M, Goldberg JF, Grossman LS, Meltzer HY. Outcome in manic disorders: a naturalistic follow-up study. Arch Gen Psychiatry. 1990;47:665-671.
3. Maj M, Pirozzi R, Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology (Berl). 1989;98:535-538.
4. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry. 1990;47:1106-1111.
5. Markar HR, Mander AJ. Efficacy of lithium prophylaxis in clinical practice. Br J Psychiatry. 1989;155:496-500.
6. Shapiro DR, Quitkin FM, Fleiss J. Response to maintenance therapy in bipolar illness: effect of index episode. Arch Gen Psychiatry. 1989;46:401-405.
7. Prien RF, Potter WZ. Psychopharmacol Bull. 1990;26:409-427 NIMH workshop report on treatment of bipolar disorder.
8. Perry A, Tarrier N, Morriss R, McCarthy E, Limb K. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. Br Med Bull. 1999;318:149-153.
9. Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, Torrent C, Comes M, Corbella B, Parramon G, Corominas J. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry. 2003;60:402-407.
10. Simon GE, Ludman E, Unuetzer J, Bauer MS. Design and implementation of a randomized trial evaluating systematic care for bipolar disorder. Bipolar Disord. 2002;4:226-236.
11. Simon GE, Ludman EJ, Unutzer J, Bauer MS, Operskalski B, Rutter C. Randomized trial of a population-based care program for people with bipolar disorder. Psychol Med. 2005;35:13-24.
12. Bauer MS, McBride L. Structured Group Psychotherapy for Bipolar Disorder: The Life Goals Program. New York, NY: Springer Publishing Co, Inc; 1996.
13. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, NY: Guilford Press; 1979.
14. Lam DH, Jones SH, Hayward P, Bright JA. Cognitive Therapy for Bipolar Disorder. Chichester, United Kingdom: John Wiley & Sons, Ltd; 1999.
15. Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N, Parr-Davis G, Sham P. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry. 2003;60:145-152.
16. Lam DH, Hayward P, Watkins ER, Wright K, Sham P. Relapse prevention in pa-tients with bipolar disorder: cognitive therapy outcome after 2 years. Am J Psychiatry. 2005;162:324-329.
17. Scott J, Garland A, Moorhead S. A pilot study of cognitive therapy in bipolar disorders. Psychol Med. 2001;31:459-467.
18. Miklowitz DJ, Goldstein MJ. Bipolar Disorder: A Family-Focused Treatment Approach. New York, NY: Gilford Press; 1997.
19. Miklowitz DJ, Goldstein MJ. Behavioral family treatment for patients with bipolar affective disorder. Behav Modif. 1990;14:457-489.
20. Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry. 2003;60:904-912.
21. Rea MM, Tompson M, Miklowitz DJ, Goldstein MJ, Hwang S, Mintz J. Familyfocused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. J Consult Clin Psychol. 2003;71:482-492.
22. Frank E, Kupfer DJ, Ehlers CL, Monk TH, Cornes CL, Carter S, Frankel DR. Interpersonal and social rhythm therapy for bipolar disorder: integrating interpersonal and behavioral approaches. Behavior Therapist. 1994;17:143-149.
23. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES. Interpersonal Psychotherapy of Depression. New York, NY: Basic Books Inc; 1984.
24. Weissman M, Markowitz J, Klerman G. A Comprehensive Guide to Interpersonal Psychotherapy. New York, NY: Basic Books Inc; 2000.
25. Ehlers CL, Frank E, Kupfer DJ. Social zeitgebers and biological rhythms: a unified approach to understanding the etiology of depression. Arch Gen Psychiatry. 1988;45:948-952.
26. Ehlers CL, Kupfer DJ, Frank E, Monk TH. Biological rhythms and depression: the role of zeitgebers and zeitstorers. Depression. 1994;1:285-293.
27. Malkoff-Schwartz S, Frank E, Anderson BP, Hlastala SA, Luther JF, Sherrill JT, Houck PR, Kupfer DJ. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol Med. 2000;30:1005-1016.
28. Malkoff-Schwartz S, Frank E, Anderson B, Sherrill JT, Siegel L, Patterson D, Kupfer DJ. Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation. Arch Gen Psychiatry. 1998;55:702-707.
29. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Colins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry. 1989;46:971-982.
30. Spitzer R, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978;35:773-782.
31. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
32. Bech P, Bolwig TG, Kramp P, Rafaelsen OJ. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr Scand. 1979;59:420-430.
33. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35:837-844.
34. First MB, Gibbon ML, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV (SCID-1): User's Guide and Interview, Research Version. New York, NY: Biometrics Research Department, New York Psychiatric Institute; 1995.
35. Thase ME, Carpenter L, Kupfer DJ, Frank E. Clinical significance of reversed vegetative subtypes of recurrent major depression. Psychopharmacol Bull. 1991;27:17-22.
36. Parkerson GR, Broadhead E, Tse CK. The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity. J Clin Epidemiol. 1993;46:379-393.
37. Monk TH, Flaherty JF, Frank E, Hoskinson K, Kupfer DJ. The Social Rhythm Metric (SRM): an instrument to quantify the daily rhythms of life. J Nerv Ment Dis. 1990;178:120-126.
38. Frank E, Kupfer DJ, Thase ME. New psychopharmacologic and psychotherapeutic strategies for long-term treatment of mood disorders. In: Costa E, Silva JA, Nadelson CC, eds. International Review of Psychiatry. Washington, DC: American Psychiatric Press; 1993:161-184.
39. Monk TH, Petrie SR, Hayes AJ, Kupfer DJ. Regularity of daily life in relation to personality, age, gender, sleep quality and circadian rhythms. J Sleep Res. 1994;3:196-205.
40. Frank E, Kupfer DJ, Wagner EF, McEachran A, Cornes C. Efficacy of interpersonal psychotherapy as a maintenance treatment for recurrent depression: contributing factors. Arch Gen Psychiatry. 1991;48:1053-1059.
41. Wagner E, Frank E, Steiner S. Discriminating maintenance treatments for recurrent depression: development and implementation of a rating scale. J Psychother Pract Res. 1992;1:280-290.
42. Frank E. Treating Bipolar Disorder: A Clinician's Guide to Interpersonal and Social Rhythm Therapy. New York, NY: Guilford Press; 2005.
43. Frank E. Interpersonal psychotherapy as a maintenance treatment for patients with recurrent depression. Psychotherapy. 1991;28:259-266.
44. Fawcett J, Epstein P, Fiester SJ, Elkin I, Autry JH. Clinical management-imipramine/placebo administration manual: NIMH Treatment of Depression Collaborative Research Program. Psychopharmacol Bull. 1987;23:309-324.
45. Frank E, Kupfer DJ, Perel JM, Cornes CL, Jarrett D, Mallinger A, Thase M, McEachran AB, Grochocinski VJ. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1990;47:1093-1099.
46. Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry. 1984;41:1096-1104.
47. Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Javna CP, Madonia MJ; EPICS Research Group. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia: I. One-year effects of a controlled study on relapse and expressed emotion. Arch Gen Psychiatry. 1986;43:633-642.
48. Leff J, Kuipers L, Berkowitz R, Eberlein-Vries R, Sturgeon D. A controlled trial of social intervention in the families of schizophrenic patients. Br J Psychiatry. 1982;141:121-134.
49. Falloon IRH, Boyd JL, McGill CW, Razoni J, Moss HB, Gilderman HA. Family management in the prevention of exacerbation of schizophrenia. N Engl J Med. 1982;306:1437-1444.
50. Tarrier N, Barrowclough C, Vaughn C, Bamrak JS, Porceddu K, Watts S, Freeman H. The community management of schizophrenia: a controlled trial of a behavioural intervention with families to reduce relapse. Br J Psychiatry. 1988;153:532-542.
51. Leff J, Berkowitz R, Shavit N, Strachan A, Glass I, Vaughn C. A trial of family therapy. V. A relatives group for schizophrenia. Br J Psychiatry. 1989;154:58-66.
52. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2004.
53. SAS Institute Inc. SAS OnlineDoc, Version 8. Cary, NC: SAS Institute Inc; 2000.
54. Diggle PJ, Kenward MG. Informative drop-out in longitudinal data analysis (with discussion). Appl Stat. 1994;43:49-93.
55. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer DJ. How do risk factors work together? Mediators, moderators, and independent, overlapping and proxy risk factors. Am J Psychiatry. 2001;158:848-856.
56. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59:877-883.
57. Ramsay JO, Silverman BW. Functional Data Analysis. New York, NY: Springer-Verlag; 1997.
58. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462-1470.
59. de Jonghe F, Kool S, van Aalst G, Dekker J, Peen J. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord. 2001;64:217-229.
60. Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, Bell B, Mills M, Chalklin L, Wallik D, Kraemer J. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord. 2002;68:317-330.
61. Ravindran AV, Anisman H, Merali Z, Charbonneau Y, Telner J, Bialik RJ, Weins A, Ellis J, Griffiths J. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. Am J Psychiatry. 1999;156:1608-1617.
62. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002;68:167-181.
63. Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, Conigliaro J, Haas GL. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6:368-373.
64. Sharma R, Markar HR. Mortality in affective disorder. J Affect Disord. 1994;31:91-96.
65. Frank E, Cyranowski JM, Rucci P, Shear MK, Fagiolini A, Thase ME, Cassano GB, Grochocinski VJ, Kostelnik B, Kupfer DJ. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch Gen Psychiatry. 2002;59:905-912.
66. Cyranowski JM, Frank E, Shear MK, Swartz H, Fagiolini A, Scott J, Kupfer DJ. Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study. Depress Anxiety. 2005;21:140-142.